BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Vancouver
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220125T183000
DTEND;TZID=America/Vancouver:20220125T200000
DTSTAMP:20260408T112150
CREATED:20220114T191754Z
LAST-MODIFIED:20220114T191754Z
UID:20246-1643135400-1643140800@scienceinvancouver.com
SUMMARY:COVID-19 Update: Expert Q&A with Public Health\, Primary Care\, Vaccine\, Epidemiology\, and Lab Specialists
DESCRIPTION:Join us for this free online accredited educational session where highly experienced and knowledgeable public health leaders and medical experts will answer your questions\, share their experiences and recommend best practices in managing the COVID-19 pandemic. The webinar will include a panel of presenters and participants will be prompted to ask their questions in real time using webinar technology. We encourage you to send your questions in early. \nFORMAT\n\nModerator and presenters visible via webcam\nPresentation slides visible on the webinar\nAudio live through your computer speakers\nYour questions sent via slido\n\nCONNECTION DETAILS\nPrior to the webinar you will receive an email from UBC CPD with connection details. If you do not receive this email\, please check your spam folders. You should add “@ubc.ca” to your safe sender list. If you do not see the connection email\, please contact us. \nHOW TO ASK QUESTIONS\n\nThe Question & Answer page is OPEN NOW – we encourage you to submit your questions early.\nGo to https://www.sli.do/ and enter the event ID # COVID-Jan25. Or go directly to https://app.sli.do/event/ppbmnpku/\nType out your question in the ‘type your question’ field and click ‘SEND’. You will see your question posted and you will be able to review questions that others have asked. Your questions can be asked anonymously\, just leave your name out when posting your questions. Due to the high volume of questions received during the webinar\, please try to avoid asking questions that have already been asked by someone else. To increase the likelihood of a particular question being asked\, please up-vote it as described in the next bullet.\nUp-vote: feel free to click the thumbs up icon beside the questions you like as this will move those questions to the top of the queue and will increase the likelihood that they will be asked of the panel.\nQuestions will be reviewed by the moderator and relayed to the presenters before the session and during the Q&A period.\n\n\n\n\nSkills Gained\n\n\nApply emerging evidence regarding COVID-19 epidemiology\, prevention\, and investigation in clinical practice\, including the use of vaccines.\nProvide practical advice to patients regarding COVID-19 based on the emerging evidence and the experience of BC public health and primary care experts.\n\n\n\n\nKey Speakers\n\nPanelist: Dr. Reka Gustafson\, Vice President\, Public Health and Wellness and Deputy Provincial Health Officer \nPanelist: Dr. Mark Lysyshyn\, Deputy Chief Medical Health Officer\, Vancouver Coastal Health \nPanelist: Dr. Mel Krajden\, Medical Director of the Public Health Laboratory\, BCCDC \nPanelist: Dr. Manish Sadarangani\, Director\, Vaccine Evaluation Center at BC Children’s Research Institute \nPanelist: Dr. Birinder Narang\, Family Physician\, Clinical Assistant Professor\, UBC Department of Family Practice \nModerator: Dr. Simon Moore\, Family Physician\, UBC CPD Medical Lead
URL:https://scienceinvancouver.com/event/covid-19-update-expert-qa-with-public-health-primary-care-vaccine-epidemiology-and-lab-specialists/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220125T183000
DTEND;TZID=America/Vancouver:20220125T200000
DTSTAMP:20260408T112150
CREATED:20220114T191754Z
LAST-MODIFIED:20220114T191754Z
UID:26496-1643135400-1643140800@scienceinvancouver.com
SUMMARY:COVID-19 Update: Expert Q&A with Public Health\, Primary Care\, Vaccine\, Epidemiology\, and Lab Specialists
DESCRIPTION:Join us for this free online accredited educational session where highly experienced and knowledgeable public health leaders and medical experts will answer your questions\, share their experiences and recommend best practices in managing the COVID-19 pandemic. The webinar will include a panel of presenters and participants will be prompted to ask their questions in real time using webinar technology. We encourage you to send your questions in early. \nFORMAT\n\nModerator and presenters visible via webcam\nPresentation slides visible on the webinar\nAudio live through your computer speakers\nYour questions sent via slido\n\nCONNECTION DETAILS\nPrior to the webinar you will receive an email from UBC CPD with connection details. If you do not receive this email\, please check your spam folders. You should add “@ubc.ca” to your safe sender list. If you do not see the connection email\, please contact us. \nHOW TO ASK QUESTIONS\n\nThe Question & Answer page is OPEN NOW – we encourage you to submit your questions early.\nGo to https://www.sli.do/ and enter the event ID # COVID-Jan25. Or go directly to https://app.sli.do/event/ppbmnpku/\nType out your question in the ‘type your question’ field and click ‘SEND’. You will see your question posted and you will be able to review questions that others have asked. Your questions can be asked anonymously\, just leave your name out when posting your questions. Due to the high volume of questions received during the webinar\, please try to avoid asking questions that have already been asked by someone else. To increase the likelihood of a particular question being asked\, please up-vote it as described in the next bullet.\nUp-vote: feel free to click the thumbs up icon beside the questions you like as this will move those questions to the top of the queue and will increase the likelihood that they will be asked of the panel.\nQuestions will be reviewed by the moderator and relayed to the presenters before the session and during the Q&A period.\n\n\n\n\nSkills Gained\n\n\nApply emerging evidence regarding COVID-19 epidemiology\, prevention\, and investigation in clinical practice\, including the use of vaccines.\nProvide practical advice to patients regarding COVID-19 based on the emerging evidence and the experience of BC public health and primary care experts.\n\n\n\n\nKey Speakers\n\nPanelist: Dr. Reka Gustafson\, Vice President\, Public Health and Wellness and Deputy Provincial Health Officer \nPanelist: Dr. Mark Lysyshyn\, Deputy Chief Medical Health Officer\, Vancouver Coastal Health \nPanelist: Dr. Mel Krajden\, Medical Director of the Public Health Laboratory\, BCCDC \nPanelist: Dr. Manish Sadarangani\, Director\, Vaccine Evaluation Center at BC Children’s Research Institute \nPanelist: Dr. Birinder Narang\, Family Physician\, Clinical Assistant Professor\, UBC Department of Family Practice \nModerator: Dr. Simon Moore\, Family Physician\, UBC CPD Medical Lead
URL:https://scienceinvancouver.com/event/covid-19-update-expert-qa-with-public-health-primary-care-vaccine-epidemiology-and-lab-specialists-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220125T183000
DTEND;TZID=America/Vancouver:20220125T200000
DTSTAMP:20260408T112150
CREATED:20220114T191754Z
LAST-MODIFIED:20220114T191754Z
UID:28111-1643135400-1643140800@scienceinvancouver.com
SUMMARY:COVID-19 Update: Expert Q&A with Public Health\, Primary Care\, Vaccine\, Epidemiology\, and Lab Specialists
DESCRIPTION:Join us for this free online accredited educational session where highly experienced and knowledgeable public health leaders and medical experts will answer your questions\, share their experiences and recommend best practices in managing the COVID-19 pandemic. The webinar will include a panel of presenters and participants will be prompted to ask their questions in real time using webinar technology. We encourage you to send your questions in early. \nFORMAT\n\nModerator and presenters visible via webcam\nPresentation slides visible on the webinar\nAudio live through your computer speakers\nYour questions sent via slido\n\nCONNECTION DETAILS\nPrior to the webinar you will receive an email from UBC CPD with connection details. If you do not receive this email\, please check your spam folders. You should add “@ubc.ca” to your safe sender list. If you do not see the connection email\, please contact us. \nHOW TO ASK QUESTIONS\n\nThe Question & Answer page is OPEN NOW – we encourage you to submit your questions early.\nGo to https://www.sli.do/ and enter the event ID # COVID-Jan25. Or go directly to https://app.sli.do/event/ppbmnpku/\nType out your question in the ‘type your question’ field and click ‘SEND’. You will see your question posted and you will be able to review questions that others have asked. Your questions can be asked anonymously\, just leave your name out when posting your questions. Due to the high volume of questions received during the webinar\, please try to avoid asking questions that have already been asked by someone else. To increase the likelihood of a particular question being asked\, please up-vote it as described in the next bullet.\nUp-vote: feel free to click the thumbs up icon beside the questions you like as this will move those questions to the top of the queue and will increase the likelihood that they will be asked of the panel.\nQuestions will be reviewed by the moderator and relayed to the presenters before the session and during the Q&A period.\n\n\n\n\nSkills Gained\n\n\nApply emerging evidence regarding COVID-19 epidemiology\, prevention\, and investigation in clinical practice\, including the use of vaccines.\nProvide practical advice to patients regarding COVID-19 based on the emerging evidence and the experience of BC public health and primary care experts.\n\n\n\n\nKey Speakers\n\nPanelist: Dr. Reka Gustafson\, Vice President\, Public Health and Wellness and Deputy Provincial Health Officer \nPanelist: Dr. Mark Lysyshyn\, Deputy Chief Medical Health Officer\, Vancouver Coastal Health \nPanelist: Dr. Mel Krajden\, Medical Director of the Public Health Laboratory\, BCCDC \nPanelist: Dr. Manish Sadarangani\, Director\, Vaccine Evaluation Center at BC Children’s Research Institute \nPanelist: Dr. Birinder Narang\, Family Physician\, Clinical Assistant Professor\, UBC Department of Family Practice \nModerator: Dr. Simon Moore\, Family Physician\, UBC CPD Medical Lead
URL:https://scienceinvancouver.com/event/covid-19-update-expert-qa-with-public-health-primary-care-vaccine-epidemiology-and-lab-specialists-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220125T183000
DTEND;TZID=America/Vancouver:20220125T200000
DTSTAMP:20260408T112150
CREATED:20220114T191754Z
LAST-MODIFIED:20220114T191754Z
UID:31194-1643135400-1643140800@scienceinvancouver.com
SUMMARY:COVID-19 Update: Expert Q&A with Public Health\, Primary Care\, Vaccine\, Epidemiology\, and Lab Specialists
DESCRIPTION:Join us for this free online accredited educational session where highly experienced and knowledgeable public health leaders and medical experts will answer your questions\, share their experiences and recommend best practices in managing the COVID-19 pandemic. The webinar will include a panel of presenters and participants will be prompted to ask their questions in real time using webinar technology. We encourage you to send your questions in early. \nFORMAT\n\nModerator and presenters visible via webcam\nPresentation slides visible on the webinar\nAudio live through your computer speakers\nYour questions sent via slido\n\nCONNECTION DETAILS\nPrior to the webinar you will receive an email from UBC CPD with connection details. If you do not receive this email\, please check your spam folders. You should add “@ubc.ca” to your safe sender list. If you do not see the connection email\, please contact us. \nHOW TO ASK QUESTIONS\n\nThe Question & Answer page is OPEN NOW – we encourage you to submit your questions early.\nGo to https://www.sli.do/ and enter the event ID # COVID-Jan25. Or go directly to https://app.sli.do/event/ppbmnpku/\nType out your question in the ‘type your question’ field and click ‘SEND’. You will see your question posted and you will be able to review questions that others have asked. Your questions can be asked anonymously\, just leave your name out when posting your questions. Due to the high volume of questions received during the webinar\, please try to avoid asking questions that have already been asked by someone else. To increase the likelihood of a particular question being asked\, please up-vote it as described in the next bullet.\nUp-vote: feel free to click the thumbs up icon beside the questions you like as this will move those questions to the top of the queue and will increase the likelihood that they will be asked of the panel.\nQuestions will be reviewed by the moderator and relayed to the presenters before the session and during the Q&A period.\n\n\n\n\nSkills Gained\n\n\nApply emerging evidence regarding COVID-19 epidemiology\, prevention\, and investigation in clinical practice\, including the use of vaccines.\nProvide practical advice to patients regarding COVID-19 based on the emerging evidence and the experience of BC public health and primary care experts.\n\n\n\n\nKey Speakers\n\nPanelist: Dr. Reka Gustafson\, Vice President\, Public Health and Wellness and Deputy Provincial Health Officer \nPanelist: Dr. Mark Lysyshyn\, Deputy Chief Medical Health Officer\, Vancouver Coastal Health \nPanelist: Dr. Mel Krajden\, Medical Director of the Public Health Laboratory\, BCCDC \nPanelist: Dr. Manish Sadarangani\, Director\, Vaccine Evaluation Center at BC Children’s Research Institute \nPanelist: Dr. Birinder Narang\, Family Physician\, Clinical Assistant Professor\, UBC Department of Family Practice \nModerator: Dr. Simon Moore\, Family Physician\, UBC CPD Medical Lead
URL:https://scienceinvancouver.com/event/covid-19-update-expert-qa-with-public-health-primary-care-vaccine-epidemiology-and-lab-specialists-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220125T183000
DTEND;TZID=America/Vancouver:20220125T200000
DTSTAMP:20260408T112150
CREATED:20220114T191754Z
LAST-MODIFIED:20220114T191754Z
UID:32654-1643135400-1643140800@scienceinvancouver.com
SUMMARY:COVID-19 Update: Expert Q&A with Public Health\, Primary Care\, Vaccine\, Epidemiology\, and Lab Specialists
DESCRIPTION:Join us for this free online accredited educational session where highly experienced and knowledgeable public health leaders and medical experts will answer your questions\, share their experiences and recommend best practices in managing the COVID-19 pandemic. The webinar will include a panel of presenters and participants will be prompted to ask their questions in real time using webinar technology. We encourage you to send your questions in early. \nFORMAT\n\nModerator and presenters visible via webcam\nPresentation slides visible on the webinar\nAudio live through your computer speakers\nYour questions sent via slido\n\nCONNECTION DETAILS\nPrior to the webinar you will receive an email from UBC CPD with connection details. If you do not receive this email\, please check your spam folders. You should add “@ubc.ca” to your safe sender list. If you do not see the connection email\, please contact us. \nHOW TO ASK QUESTIONS\n\nThe Question & Answer page is OPEN NOW – we encourage you to submit your questions early.\nGo to https://www.sli.do/ and enter the event ID # COVID-Jan25. Or go directly to https://app.sli.do/event/ppbmnpku/\nType out your question in the ‘type your question’ field and click ‘SEND’. You will see your question posted and you will be able to review questions that others have asked. Your questions can be asked anonymously\, just leave your name out when posting your questions. Due to the high volume of questions received during the webinar\, please try to avoid asking questions that have already been asked by someone else. To increase the likelihood of a particular question being asked\, please up-vote it as described in the next bullet.\nUp-vote: feel free to click the thumbs up icon beside the questions you like as this will move those questions to the top of the queue and will increase the likelihood that they will be asked of the panel.\nQuestions will be reviewed by the moderator and relayed to the presenters before the session and during the Q&A period.\n\n\n\n\nSkills Gained\n\n\nApply emerging evidence regarding COVID-19 epidemiology\, prevention\, and investigation in clinical practice\, including the use of vaccines.\nProvide practical advice to patients regarding COVID-19 based on the emerging evidence and the experience of BC public health and primary care experts.\n\n\n\n\nKey Speakers\n\nPanelist: Dr. Reka Gustafson\, Vice President\, Public Health and Wellness and Deputy Provincial Health Officer \nPanelist: Dr. Mark Lysyshyn\, Deputy Chief Medical Health Officer\, Vancouver Coastal Health \nPanelist: Dr. Mel Krajden\, Medical Director of the Public Health Laboratory\, BCCDC \nPanelist: Dr. Manish Sadarangani\, Director\, Vaccine Evaluation Center at BC Children’s Research Institute \nPanelist: Dr. Birinder Narang\, Family Physician\, Clinical Assistant Professor\, UBC Department of Family Practice \nModerator: Dr. Simon Moore\, Family Physician\, UBC CPD Medical Lead
URL:https://scienceinvancouver.com/event/covid-19-update-expert-qa-with-public-health-primary-care-vaccine-epidemiology-and-lab-specialists-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220126T150000
DTEND;TZID=America/Vancouver:20220126T163000
DTSTAMP:20260408T112150
CREATED:20220114T175424Z
LAST-MODIFIED:20220114T175424Z
UID:20242-1643209200-1643214600@scienceinvancouver.com
SUMMARY:Discovery to Commercialization
DESCRIPTION:Join us to learn about the commercialization process and entrepreneurial ventures from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. Gain insights and virtually interact with our featured panel to learn about the programs and resources available to support researchers in taking a commercialization path with their discovery. Our expert panel will also share tips and lessons learned from their experiences in getting discoveries started. \nFeatured speakers\n\nEric Atkinson\nTechnology Advisor\, National Research Council of Canada\nPat Brady\nDirector\, Industry Innovation Programs\, Genome BC\nSean Lumb\nAssociate Director\, entrepreneurship @UBC\nArushi Raina\nDirector of Commercialization\, Praxis Spinal Cord Institute\nSherry Zhao\nSenior Account Manager & Team Lead\, Mitacs\n\nRegister to attend
URL:https://scienceinvancouver.com/event/discovery-to-commercialization/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Discovery-to-Commercialization-2022.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220126T150000
DTEND;TZID=America/Vancouver:20220126T163000
DTSTAMP:20260408T112150
CREATED:20220114T175424Z
LAST-MODIFIED:20220114T175424Z
UID:26495-1643209200-1643214600@scienceinvancouver.com
SUMMARY:Discovery to Commercialization
DESCRIPTION:Join us to learn about the commercialization process and entrepreneurial ventures from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. Gain insights and virtually interact with our featured panel to learn about the programs and resources available to support researchers in taking a commercialization path with their discovery. Our expert panel will also share tips and lessons learned from their experiences in getting discoveries started. \nFeatured speakers\n\nEric Atkinson\nTechnology Advisor\, National Research Council of Canada\nPat Brady\nDirector\, Industry Innovation Programs\, Genome BC\nSean Lumb\nAssociate Director\, entrepreneurship @UBC\nArushi Raina\nDirector of Commercialization\, Praxis Spinal Cord Institute\nSherry Zhao\nSenior Account Manager & Team Lead\, Mitacs\n\nRegister to attend
URL:https://scienceinvancouver.com/event/discovery-to-commercialization-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Discovery-to-Commercialization-2022.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220126T150000
DTEND;TZID=America/Vancouver:20220126T163000
DTSTAMP:20260408T112150
CREATED:20220114T175424Z
LAST-MODIFIED:20220114T175424Z
UID:28110-1643209200-1643214600@scienceinvancouver.com
SUMMARY:Discovery to Commercialization
DESCRIPTION:Join us to learn about the commercialization process and entrepreneurial ventures from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. Gain insights and virtually interact with our featured panel to learn about the programs and resources available to support researchers in taking a commercialization path with their discovery. Our expert panel will also share tips and lessons learned from their experiences in getting discoveries started. \nFeatured speakers\n\nEric Atkinson\nTechnology Advisor\, National Research Council of Canada\nPat Brady\nDirector\, Industry Innovation Programs\, Genome BC\nSean Lumb\nAssociate Director\, entrepreneurship @UBC\nArushi Raina\nDirector of Commercialization\, Praxis Spinal Cord Institute\nSherry Zhao\nSenior Account Manager & Team Lead\, Mitacs\n\nRegister to attend
URL:https://scienceinvancouver.com/event/discovery-to-commercialization-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Discovery-to-Commercialization-2022.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220126T150000
DTEND;TZID=America/Vancouver:20220126T163000
DTSTAMP:20260408T112150
CREATED:20220114T175424Z
LAST-MODIFIED:20220114T175424Z
UID:31193-1643209200-1643214600@scienceinvancouver.com
SUMMARY:Discovery to Commercialization
DESCRIPTION:Join us to learn about the commercialization process and entrepreneurial ventures from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. Gain insights and virtually interact with our featured panel to learn about the programs and resources available to support researchers in taking a commercialization path with their discovery. Our expert panel will also share tips and lessons learned from their experiences in getting discoveries started. \nFeatured speakers\n\nEric Atkinson\nTechnology Advisor\, National Research Council of Canada\nPat Brady\nDirector\, Industry Innovation Programs\, Genome BC\nSean Lumb\nAssociate Director\, entrepreneurship @UBC\nArushi Raina\nDirector of Commercialization\, Praxis Spinal Cord Institute\nSherry Zhao\nSenior Account Manager & Team Lead\, Mitacs\n\nRegister to attend
URL:https://scienceinvancouver.com/event/discovery-to-commercialization-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Discovery-to-Commercialization-2022.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220126T150000
DTEND;TZID=America/Vancouver:20220126T163000
DTSTAMP:20260408T112150
CREATED:20220114T175424Z
LAST-MODIFIED:20220114T175424Z
UID:32653-1643209200-1643214600@scienceinvancouver.com
SUMMARY:Discovery to Commercialization
DESCRIPTION:Join us to learn about the commercialization process and entrepreneurial ventures from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. Gain insights and virtually interact with our featured panel to learn about the programs and resources available to support researchers in taking a commercialization path with their discovery. Our expert panel will also share tips and lessons learned from their experiences in getting discoveries started. \nFeatured speakers\n\nEric Atkinson\nTechnology Advisor\, National Research Council of Canada\nPat Brady\nDirector\, Industry Innovation Programs\, Genome BC\nSean Lumb\nAssociate Director\, entrepreneurship @UBC\nArushi Raina\nDirector of Commercialization\, Praxis Spinal Cord Institute\nSherry Zhao\nSenior Account Manager & Team Lead\, Mitacs\n\nRegister to attend
URL:https://scienceinvancouver.com/event/discovery-to-commercialization-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Discovery-to-Commercialization-2022.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220127T150000
DTEND;TZID=America/Vancouver:20220127T160000
DTSTAMP:20260408T112150
CREATED:20211217T224610Z
LAST-MODIFIED:20211217T224610Z
UID:19920-1643295600-1643299200@scienceinvancouver.com
SUMMARY:McCarthy Spotlight Speaking Series: Oncology
DESCRIPTION:This Spotlight Speaking Series is proudly presented by McCarthy Tétrault LLP. \nOur McCarthy Spotlight Speaking Series is one of our longest-standing event series – and one in which our attendees see the most value. Held twice a year\, these events start with presentations on specific topics by local representatives of Life Sciences BC members. \nIn the past\, the series has featured topics focusing on attracting and keeping good talent\, technology and licensing\, M&A and Capital Markets\, to name a few. \nSpeakers:\n\nFarzian Aminuddin\, Director of Business Development\, Virogin Biotech\nDr. François Bénard\, Senior Executive Director\, Research\, BC Cancer Professor\, Department of Radiology\, University of British Columbia; Associate Dean\, Research\, Faculty of Medicine\, University of British Columbia\nDr. David Mulder\, Scientist\, Canexia Health\nJim Pankovich\, EVP\, Clinical Development\, Bold Therapeutics\nDario Passarini\, Senior Manager\, Sales & Marketing\, SignalChem\n\n\n\n\n\nEvent Details:\n\nDate: Thursday\, January 27\, 2022 \nTime: 3:00 PM to 4:00 PM PT \nPlatform: Zoom \nTickets: Free for Life Sciences BC members & $25 for non-members
URL:https://scienceinvancouver.com/event/mccarthy-spotlight-speaking-series-oncology/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/McCarthy-Speaking-Event-Graphic-Jan2022.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220127T150000
DTEND;TZID=America/Vancouver:20220127T160000
DTSTAMP:20260408T112150
CREATED:20211217T224610Z
LAST-MODIFIED:20211217T224610Z
UID:26492-1643295600-1643299200@scienceinvancouver.com
SUMMARY:McCarthy Spotlight Speaking Series: Oncology
DESCRIPTION:This Spotlight Speaking Series is proudly presented by McCarthy Tétrault LLP. \nOur McCarthy Spotlight Speaking Series is one of our longest-standing event series – and one in which our attendees see the most value. Held twice a year\, these events start with presentations on specific topics by local representatives of Life Sciences BC members. \nIn the past\, the series has featured topics focusing on attracting and keeping good talent\, technology and licensing\, M&A and Capital Markets\, to name a few. \nSpeakers:\n\nFarzian Aminuddin\, Director of Business Development\, Virogin Biotech\nDr. François Bénard\, Senior Executive Director\, Research\, BC Cancer Professor\, Department of Radiology\, University of British Columbia; Associate Dean\, Research\, Faculty of Medicine\, University of British Columbia\nDr. David Mulder\, Scientist\, Canexia Health\nJim Pankovich\, EVP\, Clinical Development\, Bold Therapeutics\nDario Passarini\, Senior Manager\, Sales & Marketing\, SignalChem\n\n\n\n\n\nEvent Details:\n\nDate: Thursday\, January 27\, 2022 \nTime: 3:00 PM to 4:00 PM PT \nPlatform: Zoom \nTickets: Free for Life Sciences BC members & $25 for non-members
URL:https://scienceinvancouver.com/event/mccarthy-spotlight-speaking-series-oncology-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/McCarthy-Speaking-Event-Graphic-Jan2022.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220127T150000
DTEND;TZID=America/Vancouver:20220127T160000
DTSTAMP:20260408T112150
CREATED:20211217T224610Z
LAST-MODIFIED:20211217T224610Z
UID:28107-1643295600-1643299200@scienceinvancouver.com
SUMMARY:McCarthy Spotlight Speaking Series: Oncology
DESCRIPTION:This Spotlight Speaking Series is proudly presented by McCarthy Tétrault LLP. \nOur McCarthy Spotlight Speaking Series is one of our longest-standing event series – and one in which our attendees see the most value. Held twice a year\, these events start with presentations on specific topics by local representatives of Life Sciences BC members. \nIn the past\, the series has featured topics focusing on attracting and keeping good talent\, technology and licensing\, M&A and Capital Markets\, to name a few. \nSpeakers:\n\nFarzian Aminuddin\, Director of Business Development\, Virogin Biotech\nDr. François Bénard\, Senior Executive Director\, Research\, BC Cancer Professor\, Department of Radiology\, University of British Columbia; Associate Dean\, Research\, Faculty of Medicine\, University of British Columbia\nDr. David Mulder\, Scientist\, Canexia Health\nJim Pankovich\, EVP\, Clinical Development\, Bold Therapeutics\nDario Passarini\, Senior Manager\, Sales & Marketing\, SignalChem\n\n\n\n\n\nEvent Details:\n\nDate: Thursday\, January 27\, 2022 \nTime: 3:00 PM to 4:00 PM PT \nPlatform: Zoom \nTickets: Free for Life Sciences BC members & $25 for non-members
URL:https://scienceinvancouver.com/event/mccarthy-spotlight-speaking-series-oncology-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/McCarthy-Speaking-Event-Graphic-Jan2022.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220127T150000
DTEND;TZID=America/Vancouver:20220127T160000
DTSTAMP:20260408T112150
CREATED:20211217T224610Z
LAST-MODIFIED:20211217T224610Z
UID:31190-1643295600-1643299200@scienceinvancouver.com
SUMMARY:McCarthy Spotlight Speaking Series: Oncology
DESCRIPTION:This Spotlight Speaking Series is proudly presented by McCarthy Tétrault LLP. \nOur McCarthy Spotlight Speaking Series is one of our longest-standing event series – and one in which our attendees see the most value. Held twice a year\, these events start with presentations on specific topics by local representatives of Life Sciences BC members. \nIn the past\, the series has featured topics focusing on attracting and keeping good talent\, technology and licensing\, M&A and Capital Markets\, to name a few. \nSpeakers:\n\nFarzian Aminuddin\, Director of Business Development\, Virogin Biotech\nDr. François Bénard\, Senior Executive Director\, Research\, BC Cancer Professor\, Department of Radiology\, University of British Columbia; Associate Dean\, Research\, Faculty of Medicine\, University of British Columbia\nDr. David Mulder\, Scientist\, Canexia Health\nJim Pankovich\, EVP\, Clinical Development\, Bold Therapeutics\nDario Passarini\, Senior Manager\, Sales & Marketing\, SignalChem\n\n\n\n\n\nEvent Details:\n\nDate: Thursday\, January 27\, 2022 \nTime: 3:00 PM to 4:00 PM PT \nPlatform: Zoom \nTickets: Free for Life Sciences BC members & $25 for non-members
URL:https://scienceinvancouver.com/event/mccarthy-spotlight-speaking-series-oncology-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/McCarthy-Speaking-Event-Graphic-Jan2022.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220127T150000
DTEND;TZID=America/Vancouver:20220127T160000
DTSTAMP:20260408T112150
CREATED:20211217T224610Z
LAST-MODIFIED:20211217T224610Z
UID:32650-1643295600-1643299200@scienceinvancouver.com
SUMMARY:McCarthy Spotlight Speaking Series: Oncology
DESCRIPTION:This Spotlight Speaking Series is proudly presented by McCarthy Tétrault LLP. \nOur McCarthy Spotlight Speaking Series is one of our longest-standing event series – and one in which our attendees see the most value. Held twice a year\, these events start with presentations on specific topics by local representatives of Life Sciences BC members. \nIn the past\, the series has featured topics focusing on attracting and keeping good talent\, technology and licensing\, M&A and Capital Markets\, to name a few. \nSpeakers:\n\nFarzian Aminuddin\, Director of Business Development\, Virogin Biotech\nDr. François Bénard\, Senior Executive Director\, Research\, BC Cancer Professor\, Department of Radiology\, University of British Columbia; Associate Dean\, Research\, Faculty of Medicine\, University of British Columbia\nDr. David Mulder\, Scientist\, Canexia Health\nJim Pankovich\, EVP\, Clinical Development\, Bold Therapeutics\nDario Passarini\, Senior Manager\, Sales & Marketing\, SignalChem\n\n\n\n\n\nEvent Details:\n\nDate: Thursday\, January 27\, 2022 \nTime: 3:00 PM to 4:00 PM PT \nPlatform: Zoom \nTickets: Free for Life Sciences BC members & $25 for non-members
URL:https://scienceinvancouver.com/event/mccarthy-spotlight-speaking-series-oncology-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/12/McCarthy-Speaking-Event-Graphic-Jan2022.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220127T170000
DTEND;TZID=America/Vancouver:20220127T183000
DTSTAMP:20260408T112150
CREATED:20220126T184344Z
LAST-MODIFIED:20220126T184344Z
UID:20440-1643302800-1643308200@scienceinvancouver.com
SUMMARY:SFU Café Scientifique — The Immune System: Our Great Protector Against Dangerous Stuff
DESCRIPTION:Our bodies are constantly in contact with material in the environment\, such as microbes\, that are harmful to our health. Despite this\, most people are healthy because the immune system patrols our bodies and protects us from these harmful environmental components. In this Cafe Scientifique\, Dr. Jonathan Choy from the Department of Molecular Biology and Biochemistry will discuss how the immune system does this. \nJanuary 27th\, 2022 \n5-6:30PM
URL:https://scienceinvancouver.com/event/sfu-cafe-scientifique-the-immune-system-our-great-protector-against-dangerous-stuff/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220127T170000
DTEND;TZID=America/Vancouver:20220127T183000
DTSTAMP:20260408T112150
CREATED:20220126T184344Z
LAST-MODIFIED:20220126T184344Z
UID:26499-1643302800-1643308200@scienceinvancouver.com
SUMMARY:SFU Café Scientifique — The Immune System: Our Great Protector Against Dangerous Stuff
DESCRIPTION:Our bodies are constantly in contact with material in the environment\, such as microbes\, that are harmful to our health. Despite this\, most people are healthy because the immune system patrols our bodies and protects us from these harmful environmental components. In this Cafe Scientifique\, Dr. Jonathan Choy from the Department of Molecular Biology and Biochemistry will discuss how the immune system does this. \nJanuary 27th\, 2022 \n5-6:30PM
URL:https://scienceinvancouver.com/event/sfu-cafe-scientifique-the-immune-system-our-great-protector-against-dangerous-stuff-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220127T170000
DTEND;TZID=America/Vancouver:20220127T183000
DTSTAMP:20260408T112150
CREATED:20220126T184344Z
LAST-MODIFIED:20220126T184344Z
UID:28114-1643302800-1643308200@scienceinvancouver.com
SUMMARY:SFU Café Scientifique — The Immune System: Our Great Protector Against Dangerous Stuff
DESCRIPTION:Our bodies are constantly in contact with material in the environment\, such as microbes\, that are harmful to our health. Despite this\, most people are healthy because the immune system patrols our bodies and protects us from these harmful environmental components. In this Cafe Scientifique\, Dr. Jonathan Choy from the Department of Molecular Biology and Biochemistry will discuss how the immune system does this. \nJanuary 27th\, 2022 \n5-6:30PM
URL:https://scienceinvancouver.com/event/sfu-cafe-scientifique-the-immune-system-our-great-protector-against-dangerous-stuff-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220127T170000
DTEND;TZID=America/Vancouver:20220127T183000
DTSTAMP:20260408T112150
CREATED:20220126T184344Z
LAST-MODIFIED:20220126T184344Z
UID:31197-1643302800-1643308200@scienceinvancouver.com
SUMMARY:SFU Café Scientifique — The Immune System: Our Great Protector Against Dangerous Stuff
DESCRIPTION:Our bodies are constantly in contact with material in the environment\, such as microbes\, that are harmful to our health. Despite this\, most people are healthy because the immune system patrols our bodies and protects us from these harmful environmental components. In this Cafe Scientifique\, Dr. Jonathan Choy from the Department of Molecular Biology and Biochemistry will discuss how the immune system does this. \nJanuary 27th\, 2022 \n5-6:30PM
URL:https://scienceinvancouver.com/event/sfu-cafe-scientifique-the-immune-system-our-great-protector-against-dangerous-stuff-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220127T170000
DTEND;TZID=America/Vancouver:20220127T183000
DTSTAMP:20260408T112150
CREATED:20220126T184344Z
LAST-MODIFIED:20220126T184344Z
UID:32657-1643302800-1643308200@scienceinvancouver.com
SUMMARY:SFU Café Scientifique — The Immune System: Our Great Protector Against Dangerous Stuff
DESCRIPTION:Our bodies are constantly in contact with material in the environment\, such as microbes\, that are harmful to our health. Despite this\, most people are healthy because the immune system patrols our bodies and protects us from these harmful environmental components. In this Cafe Scientifique\, Dr. Jonathan Choy from the Department of Molecular Biology and Biochemistry will discuss how the immune system does this. \nJanuary 27th\, 2022 \n5-6:30PM
URL:https://scienceinvancouver.com/event/sfu-cafe-scientifique-the-immune-system-our-great-protector-against-dangerous-stuff-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220202T110000
DTEND;TZID=America/Vancouver:20220202T120000
DTSTAMP:20260408T112150
CREATED:20220128T194200Z
LAST-MODIFIED:20220131T192352Z
UID:20518-1643799600-1643803200@scienceinvancouver.com
SUMMARY:Gamma Fibrinogen and COVID-19; Who Knew?
DESCRIPTION:Dr. David Farrell \nProfessor of Surgery\, Oregon Health & Science University\nFounder and Chief Scientific Officer of Gamma Diagnostics \nIntroduction: COVID-19 disease progression can be accompanied by a “cytokine storm” that leads to secondary\nsequelae such as thrombosis and acute respiratory distress syndrome. Several inflammatory cytokines have been\nassociated with COVID-19 disease progression\, but have far too much daily intra-individual variability to be useful\nin tracking the course of the disease. In contrast\, we have shown that the inflammatory biomarker γ’ fibrinogen (γ’\nFbg) has a 6-fold lower coefficient of variability compared to other inflammatory markers such as hs-CRP. The aims\nof the study were to measure γ’ Fbg in serial blood samples from COVID-19 patients at a tertiary care medical\ncenter in order to investigate its association with clinical measures of disease progression. \nHypothesis: Our hypothesis was that γ’ Fbg levels would be elevated in COVID-19 patients compared to historical\ncontrols\, and that the degree of elevation would be associated with disease severity. \nMethods: COVID-19 patients at a tertiary care medical center were retrospectively enrolled between 3/16/2020\nand 8/1/2020. γ’ Fbg was measured using the GammaCoeur ELISA (Gamma Diagnostics\, Patent Pending). \nResults: Our results showed that ten out of the eighteen patients with COVID-19 had the highest levels of γ’ Fbg\never recorded. The previous highest γ’ Fbg level of 80.3 mg/dL was found in a study of 10\,601 participants in the\nARIC study. γ’ Fbg levels were significantly associated with the need for ECMO and mortality.\nConclusions: We found that COVID-19 patients can develop extraordinarily high levels of γ’ Fbg. This has several\nimportant clinical implications. γ’ Fbg contains a high affinity binding site for thrombin that binds to anion-binding\nexosite II on thrombin and protects it from inactivation by heparin. High levels of γ’ Fbg therefore provide a\nreservoir of heparin-resistant clot-bound thrombin when the γ’ Fbg is clotted. These findings have potential\nclinical implications regarding prophylactic anticoagulation of COVID-19 patients and suggest that heparin\nprophylaxis may be less effective than using other anticoagulants\, particularly direct thrombin inhibitors.
URL:https://scienceinvancouver.com/event/gamma-fibrinogen-and-covid-19-who-knew/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220202T110000
DTEND;TZID=America/Vancouver:20220202T120000
DTSTAMP:20260408T112150
CREATED:20220128T194200Z
LAST-MODIFIED:20220128T194200Z
UID:26503-1643799600-1643803200@scienceinvancouver.com
SUMMARY:Gamma Fibrinogen and COVID-19; Who Knew?
DESCRIPTION:Dr. David Farrell \nProfessor of Surgery\, Oregon Health & Science University\nFounder and Chief Scientific Officer of Gamma Diagnostics \nIntroduction: COVID-19 disease progression can be accompanied by a “cytokine storm” that leads to secondary\nsequelae such as thrombosis and acute respiratory distress syndrome. Several inflammatory cytokines have been\nassociated with COVID-19 disease progression\, but have far too much daily intra-individual variability to be useful\nin tracking the course of the disease. In contrast\, we have shown that the inflammatory biomarker γ’ fibrinogen (γ’\nFbg) has a 6-fold lower coefficient of variability compared to other inflammatory markers such as hs-CRP. The aims\nof the study were to measure γ’ Fbg in serial blood samples from COVID-19 patients at a tertiary care medical\ncenter in order to investigate its association with clinical measures of disease progression. \nHypothesis: Our hypothesis was that γ’ Fbg levels would be elevated in COVID-19 patients compared to historical\ncontrols\, and that the degree of elevation would be associated with disease severity. \nMethods: COVID-19 patients at a tertiary care medical center were retrospectively enrolled between 3/16/2020\nand 8/1/2020. γ’ Fbg was measured using the GammaCoeur ELISA (Gamma Diagnostics\, Patent Pending). \nResults: Our results showed that ten out of the eighteen patients with COVID-19 had the highest levels of γ’ Fbg\never recorded. The previous highest γ’ Fbg level of 80.3 mg/dL was found in a study of 10\,601 participants in the\nARIC study. γ’ Fbg levels were significantly associated with the need for ECMO and mortality.\nConclusions: We found that COVID-19 patients can develop extraordinarily high levels of γ’ Fbg. This has several\nimportant clinical implications. γ’ Fbg contains a high affinity binding site for thrombin that binds to anion-binding\nexosite II on thrombin and protects it from inactivation by heparin. High levels of γ’ Fbg therefore provide a\nreservoir of heparin-resistant clot-bound thrombin when the γ’ Fbg is clotted. These findings have potential\nclinical implications regarding prophylactic anticoagulation of COVID-19 patients and suggest that heparin\nprophylaxis may be less effective than using other anticoagulants\, particularly direct thrombin inhibitors.
URL:https://scienceinvancouver.com/event/gamma-fibrinogen-and-covid-19-who-knew-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220202T110000
DTEND;TZID=America/Vancouver:20220202T120000
DTSTAMP:20260408T112150
CREATED:20220128T194200Z
LAST-MODIFIED:20220128T194200Z
UID:28118-1643799600-1643803200@scienceinvancouver.com
SUMMARY:Gamma Fibrinogen and COVID-19; Who Knew?
DESCRIPTION:Dr. David Farrell \nProfessor of Surgery\, Oregon Health & Science University\nFounder and Chief Scientific Officer of Gamma Diagnostics \nIntroduction: COVID-19 disease progression can be accompanied by a “cytokine storm” that leads to secondary\nsequelae such as thrombosis and acute respiratory distress syndrome. Several inflammatory cytokines have been\nassociated with COVID-19 disease progression\, but have far too much daily intra-individual variability to be useful\nin tracking the course of the disease. In contrast\, we have shown that the inflammatory biomarker γ’ fibrinogen (γ’\nFbg) has a 6-fold lower coefficient of variability compared to other inflammatory markers such as hs-CRP. The aims\nof the study were to measure γ’ Fbg in serial blood samples from COVID-19 patients at a tertiary care medical\ncenter in order to investigate its association with clinical measures of disease progression. \nHypothesis: Our hypothesis was that γ’ Fbg levels would be elevated in COVID-19 patients compared to historical\ncontrols\, and that the degree of elevation would be associated with disease severity. \nMethods: COVID-19 patients at a tertiary care medical center were retrospectively enrolled between 3/16/2020\nand 8/1/2020. γ’ Fbg was measured using the GammaCoeur ELISA (Gamma Diagnostics\, Patent Pending). \nResults: Our results showed that ten out of the eighteen patients with COVID-19 had the highest levels of γ’ Fbg\never recorded. The previous highest γ’ Fbg level of 80.3 mg/dL was found in a study of 10\,601 participants in the\nARIC study. γ’ Fbg levels were significantly associated with the need for ECMO and mortality.\nConclusions: We found that COVID-19 patients can develop extraordinarily high levels of γ’ Fbg. This has several\nimportant clinical implications. γ’ Fbg contains a high affinity binding site for thrombin that binds to anion-binding\nexosite II on thrombin and protects it from inactivation by heparin. High levels of γ’ Fbg therefore provide a\nreservoir of heparin-resistant clot-bound thrombin when the γ’ Fbg is clotted. These findings have potential\nclinical implications regarding prophylactic anticoagulation of COVID-19 patients and suggest that heparin\nprophylaxis may be less effective than using other anticoagulants\, particularly direct thrombin inhibitors.
URL:https://scienceinvancouver.com/event/gamma-fibrinogen-and-covid-19-who-knew-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220202T110000
DTEND;TZID=America/Vancouver:20220202T120000
DTSTAMP:20260408T112150
CREATED:20220128T194200Z
LAST-MODIFIED:20220128T194200Z
UID:31201-1643799600-1643803200@scienceinvancouver.com
SUMMARY:Gamma Fibrinogen and COVID-19; Who Knew?
DESCRIPTION:Dr. David Farrell \nProfessor of Surgery\, Oregon Health & Science University\nFounder and Chief Scientific Officer of Gamma Diagnostics \nIntroduction: COVID-19 disease progression can be accompanied by a “cytokine storm” that leads to secondary\nsequelae such as thrombosis and acute respiratory distress syndrome. Several inflammatory cytokines have been\nassociated with COVID-19 disease progression\, but have far too much daily intra-individual variability to be useful\nin tracking the course of the disease. In contrast\, we have shown that the inflammatory biomarker γ’ fibrinogen (γ’\nFbg) has a 6-fold lower coefficient of variability compared to other inflammatory markers such as hs-CRP. The aims\nof the study were to measure γ’ Fbg in serial blood samples from COVID-19 patients at a tertiary care medical\ncenter in order to investigate its association with clinical measures of disease progression. \nHypothesis: Our hypothesis was that γ’ Fbg levels would be elevated in COVID-19 patients compared to historical\ncontrols\, and that the degree of elevation would be associated with disease severity. \nMethods: COVID-19 patients at a tertiary care medical center were retrospectively enrolled between 3/16/2020\nand 8/1/2020. γ’ Fbg was measured using the GammaCoeur ELISA (Gamma Diagnostics\, Patent Pending). \nResults: Our results showed that ten out of the eighteen patients with COVID-19 had the highest levels of γ’ Fbg\never recorded. The previous highest γ’ Fbg level of 80.3 mg/dL was found in a study of 10\,601 participants in the\nARIC study. γ’ Fbg levels were significantly associated with the need for ECMO and mortality.\nConclusions: We found that COVID-19 patients can develop extraordinarily high levels of γ’ Fbg. This has several\nimportant clinical implications. γ’ Fbg contains a high affinity binding site for thrombin that binds to anion-binding\nexosite II on thrombin and protects it from inactivation by heparin. High levels of γ’ Fbg therefore provide a\nreservoir of heparin-resistant clot-bound thrombin when the γ’ Fbg is clotted. These findings have potential\nclinical implications regarding prophylactic anticoagulation of COVID-19 patients and suggest that heparin\nprophylaxis may be less effective than using other anticoagulants\, particularly direct thrombin inhibitors.
URL:https://scienceinvancouver.com/event/gamma-fibrinogen-and-covid-19-who-knew-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220202T110000
DTEND;TZID=America/Vancouver:20220202T120000
DTSTAMP:20260408T112150
CREATED:20220128T194200Z
LAST-MODIFIED:20220128T194200Z
UID:32661-1643799600-1643803200@scienceinvancouver.com
SUMMARY:Gamma Fibrinogen and COVID-19; Who Knew?
DESCRIPTION:Dr. David Farrell \nProfessor of Surgery\, Oregon Health & Science University\nFounder and Chief Scientific Officer of Gamma Diagnostics \nIntroduction: COVID-19 disease progression can be accompanied by a “cytokine storm” that leads to secondary\nsequelae such as thrombosis and acute respiratory distress syndrome. Several inflammatory cytokines have been\nassociated with COVID-19 disease progression\, but have far too much daily intra-individual variability to be useful\nin tracking the course of the disease. In contrast\, we have shown that the inflammatory biomarker γ’ fibrinogen (γ’\nFbg) has a 6-fold lower coefficient of variability compared to other inflammatory markers such as hs-CRP. The aims\nof the study were to measure γ’ Fbg in serial blood samples from COVID-19 patients at a tertiary care medical\ncenter in order to investigate its association with clinical measures of disease progression. \nHypothesis: Our hypothesis was that γ’ Fbg levels would be elevated in COVID-19 patients compared to historical\ncontrols\, and that the degree of elevation would be associated with disease severity. \nMethods: COVID-19 patients at a tertiary care medical center were retrospectively enrolled between 3/16/2020\nand 8/1/2020. γ’ Fbg was measured using the GammaCoeur ELISA (Gamma Diagnostics\, Patent Pending). \nResults: Our results showed that ten out of the eighteen patients with COVID-19 had the highest levels of γ’ Fbg\never recorded. The previous highest γ’ Fbg level of 80.3 mg/dL was found in a study of 10\,601 participants in the\nARIC study. γ’ Fbg levels were significantly associated with the need for ECMO and mortality.\nConclusions: We found that COVID-19 patients can develop extraordinarily high levels of γ’ Fbg. This has several\nimportant clinical implications. γ’ Fbg contains a high affinity binding site for thrombin that binds to anion-binding\nexosite II on thrombin and protects it from inactivation by heparin. High levels of γ’ Fbg therefore provide a\nreservoir of heparin-resistant clot-bound thrombin when the γ’ Fbg is clotted. These findings have potential\nclinical implications regarding prophylactic anticoagulation of COVID-19 patients and suggest that heparin\nprophylaxis may be less effective than using other anticoagulants\, particularly direct thrombin inhibitors.
URL:https://scienceinvancouver.com/event/gamma-fibrinogen-and-covid-19-who-knew-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220202T170000
DTEND;TZID=America/Vancouver:20220202T180000
DTSTAMP:20260408T112150
CREATED:20220127T202811Z
LAST-MODIFIED:20220127T202811Z
UID:20476-1643821200-1643824800@scienceinvancouver.com
SUMMARY:Connect with Biotech and Life Sciences Professionals: Dr. Lorena Braid
DESCRIPTION:Connect with Dr. Lorena Braid\, Assistant Professor in the MBB Department at SFU\, Founder and Chief Science Officer of Aurora BioSolutions\n\n\n\n\n\n\n\nThe SBN is pleased to announce our first event of the Connect with Biotech and Life Sciences Professional Series for 2022. We are delighted to be joined by Dr. Lorena Braid\, Assistant Professor in the MBB Department at SFU\, Founder and Chief Science Officer of Aurora BioSolutions. \nDr. Lorena R. Braid is an Assistant Professor in the MBB department at Simon Fraser University. She holds a Canada Research Chair in Mesenchymal Stromal Cell Biology\, an award that recognizes exceptional early career researchers and emerging leaders in their fields. She is also the Founder and Chief Science Officer of Aurora BioSolutions\, where she leads a research team developing stem cell-based therapeutics for biological and chemical defence and severe burn injury. Dr. Braid was awarded a Ph.D. in Molecular Biology and Biochemistry by Simon Fraser University in 2011\, supported by seven competitive doctoral scholarships. In 2014\, Dr. Braid completed an NSERC Visiting Fellowship at Defence Research and Development Canada\, which explored the usefulness of stem cells for the Canadian Armed Forces and launched her current research programs. She is an active member of the International Society for Stem Cell Research (ISSCR) and International Society for Cell and Gene Therapy (ISCT)\, BCRegMed and Life Sciences BC. \nThrough this opportunity\, students can expect to: \n\nLearn about careers in the life sciences and biotech industry\nEngage with Dr. Lorena Braid\nQ&A with Dr. Lorena Braid\n\nDue to the nature of the event\, there will be limited attendance. Those that are unable to secure a spot will be put on a waitlist.
URL:https://scienceinvancouver.com/event/connect-with-biotech-and-life-sciences-professionals-dr-lorena-braid/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Lorena-Braid-SBN.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220202T170000
DTEND;TZID=America/Vancouver:20220202T180000
DTSTAMP:20260408T112150
CREATED:20220127T202811Z
LAST-MODIFIED:20220127T202811Z
UID:26502-1643821200-1643824800@scienceinvancouver.com
SUMMARY:Connect with Biotech and Life Sciences Professionals: Dr. Lorena Braid
DESCRIPTION:Connect with Dr. Lorena Braid\, Assistant Professor in the MBB Department at SFU\, Founder and Chief Science Officer of Aurora BioSolutions\n\n\n\n\n\n\n\nThe SBN is pleased to announce our first event of the Connect with Biotech and Life Sciences Professional Series for 2022. We are delighted to be joined by Dr. Lorena Braid\, Assistant Professor in the MBB Department at SFU\, Founder and Chief Science Officer of Aurora BioSolutions. \nDr. Lorena R. Braid is an Assistant Professor in the MBB department at Simon Fraser University. She holds a Canada Research Chair in Mesenchymal Stromal Cell Biology\, an award that recognizes exceptional early career researchers and emerging leaders in their fields. She is also the Founder and Chief Science Officer of Aurora BioSolutions\, where she leads a research team developing stem cell-based therapeutics for biological and chemical defence and severe burn injury. Dr. Braid was awarded a Ph.D. in Molecular Biology and Biochemistry by Simon Fraser University in 2011\, supported by seven competitive doctoral scholarships. In 2014\, Dr. Braid completed an NSERC Visiting Fellowship at Defence Research and Development Canada\, which explored the usefulness of stem cells for the Canadian Armed Forces and launched her current research programs. She is an active member of the International Society for Stem Cell Research (ISSCR) and International Society for Cell and Gene Therapy (ISCT)\, BCRegMed and Life Sciences BC. \nThrough this opportunity\, students can expect to: \n\nLearn about careers in the life sciences and biotech industry\nEngage with Dr. Lorena Braid\nQ&A with Dr. Lorena Braid\n\nDue to the nature of the event\, there will be limited attendance. Those that are unable to secure a spot will be put on a waitlist.
URL:https://scienceinvancouver.com/event/connect-with-biotech-and-life-sciences-professionals-dr-lorena-braid-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Lorena-Braid-SBN.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220202T170000
DTEND;TZID=America/Vancouver:20220202T180000
DTSTAMP:20260408T112150
CREATED:20220127T202811Z
LAST-MODIFIED:20220127T202811Z
UID:28117-1643821200-1643824800@scienceinvancouver.com
SUMMARY:Connect with Biotech and Life Sciences Professionals: Dr. Lorena Braid
DESCRIPTION:Connect with Dr. Lorena Braid\, Assistant Professor in the MBB Department at SFU\, Founder and Chief Science Officer of Aurora BioSolutions\n\n\n\n\n\n\n\nThe SBN is pleased to announce our first event of the Connect with Biotech and Life Sciences Professional Series for 2022. We are delighted to be joined by Dr. Lorena Braid\, Assistant Professor in the MBB Department at SFU\, Founder and Chief Science Officer of Aurora BioSolutions. \nDr. Lorena R. Braid is an Assistant Professor in the MBB department at Simon Fraser University. She holds a Canada Research Chair in Mesenchymal Stromal Cell Biology\, an award that recognizes exceptional early career researchers and emerging leaders in their fields. She is also the Founder and Chief Science Officer of Aurora BioSolutions\, where she leads a research team developing stem cell-based therapeutics for biological and chemical defence and severe burn injury. Dr. Braid was awarded a Ph.D. in Molecular Biology and Biochemistry by Simon Fraser University in 2011\, supported by seven competitive doctoral scholarships. In 2014\, Dr. Braid completed an NSERC Visiting Fellowship at Defence Research and Development Canada\, which explored the usefulness of stem cells for the Canadian Armed Forces and launched her current research programs. She is an active member of the International Society for Stem Cell Research (ISSCR) and International Society for Cell and Gene Therapy (ISCT)\, BCRegMed and Life Sciences BC. \nThrough this opportunity\, students can expect to: \n\nLearn about careers in the life sciences and biotech industry\nEngage with Dr. Lorena Braid\nQ&A with Dr. Lorena Braid\n\nDue to the nature of the event\, there will be limited attendance. Those that are unable to secure a spot will be put on a waitlist.
URL:https://scienceinvancouver.com/event/connect-with-biotech-and-life-sciences-professionals-dr-lorena-braid-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Lorena-Braid-SBN.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220202T170000
DTEND;TZID=America/Vancouver:20220202T180000
DTSTAMP:20260408T112150
CREATED:20220127T202811Z
LAST-MODIFIED:20220127T202811Z
UID:31200-1643821200-1643824800@scienceinvancouver.com
SUMMARY:Connect with Biotech and Life Sciences Professionals: Dr. Lorena Braid
DESCRIPTION:Connect with Dr. Lorena Braid\, Assistant Professor in the MBB Department at SFU\, Founder and Chief Science Officer of Aurora BioSolutions\n\n\n\n\n\n\n\nThe SBN is pleased to announce our first event of the Connect with Biotech and Life Sciences Professional Series for 2022. We are delighted to be joined by Dr. Lorena Braid\, Assistant Professor in the MBB Department at SFU\, Founder and Chief Science Officer of Aurora BioSolutions. \nDr. Lorena R. Braid is an Assistant Professor in the MBB department at Simon Fraser University. She holds a Canada Research Chair in Mesenchymal Stromal Cell Biology\, an award that recognizes exceptional early career researchers and emerging leaders in their fields. She is also the Founder and Chief Science Officer of Aurora BioSolutions\, where she leads a research team developing stem cell-based therapeutics for biological and chemical defence and severe burn injury. Dr. Braid was awarded a Ph.D. in Molecular Biology and Biochemistry by Simon Fraser University in 2011\, supported by seven competitive doctoral scholarships. In 2014\, Dr. Braid completed an NSERC Visiting Fellowship at Defence Research and Development Canada\, which explored the usefulness of stem cells for the Canadian Armed Forces and launched her current research programs. She is an active member of the International Society for Stem Cell Research (ISSCR) and International Society for Cell and Gene Therapy (ISCT)\, BCRegMed and Life Sciences BC. \nThrough this opportunity\, students can expect to: \n\nLearn about careers in the life sciences and biotech industry\nEngage with Dr. Lorena Braid\nQ&A with Dr. Lorena Braid\n\nDue to the nature of the event\, there will be limited attendance. Those that are unable to secure a spot will be put on a waitlist.
URL:https://scienceinvancouver.com/event/connect-with-biotech-and-life-sciences-professionals-dr-lorena-braid-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Lorena-Braid-SBN.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220202T170000
DTEND;TZID=America/Vancouver:20220202T180000
DTSTAMP:20260408T112150
CREATED:20220127T202811Z
LAST-MODIFIED:20220127T202811Z
UID:32660-1643821200-1643824800@scienceinvancouver.com
SUMMARY:Connect with Biotech and Life Sciences Professionals: Dr. Lorena Braid
DESCRIPTION:Connect with Dr. Lorena Braid\, Assistant Professor in the MBB Department at SFU\, Founder and Chief Science Officer of Aurora BioSolutions\n\n\n\n\n\n\n\nThe SBN is pleased to announce our first event of the Connect with Biotech and Life Sciences Professional Series for 2022. We are delighted to be joined by Dr. Lorena Braid\, Assistant Professor in the MBB Department at SFU\, Founder and Chief Science Officer of Aurora BioSolutions. \nDr. Lorena R. Braid is an Assistant Professor in the MBB department at Simon Fraser University. She holds a Canada Research Chair in Mesenchymal Stromal Cell Biology\, an award that recognizes exceptional early career researchers and emerging leaders in their fields. She is also the Founder and Chief Science Officer of Aurora BioSolutions\, where she leads a research team developing stem cell-based therapeutics for biological and chemical defence and severe burn injury. Dr. Braid was awarded a Ph.D. in Molecular Biology and Biochemistry by Simon Fraser University in 2011\, supported by seven competitive doctoral scholarships. In 2014\, Dr. Braid completed an NSERC Visiting Fellowship at Defence Research and Development Canada\, which explored the usefulness of stem cells for the Canadian Armed Forces and launched her current research programs. She is an active member of the International Society for Stem Cell Research (ISSCR) and International Society for Cell and Gene Therapy (ISCT)\, BCRegMed and Life Sciences BC. \nThrough this opportunity\, students can expect to: \n\nLearn about careers in the life sciences and biotech industry\nEngage with Dr. Lorena Braid\nQ&A with Dr. Lorena Braid\n\nDue to the nature of the event\, there will be limited attendance. Those that are unable to secure a spot will be put on a waitlist.
URL:https://scienceinvancouver.com/event/connect-with-biotech-and-life-sciences-professionals-dr-lorena-braid-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2022/01/Lorena-Braid-SBN.png
END:VEVENT
END:VCALENDAR